Skip to main content
Top
Published in: Journal of Cancer Education 3/2011

01-09-2011

Teaching Oncology to Medical Students is a Must: The Egyptian NCI Step on the Road

Authors: Rabab Gaafar, Emad Shash, Alaa El-Haddad, Salah Abdel Hady

Published in: Journal of Cancer Education | Issue 3/2011

Login to get access

Excerpt

Pavlidis et al. [1] recently published their experience in teaching oncology to undergraduate medical students over a 6-year-period which involved a 5-day intense summer course that was organized by the European School of Oncology. They highlighted that a limited perception of oncology as a separate entity in the medical school curriculum is associated with a poorer understanding of various aspects of cancer management [1, 2]. …
Literature
2.
go back to reference Pavlidis N, Vermorken JB, Stahel R et al (2007) Oncology for medical students: a European school of oncology contribution to undergraduate cancer education. Cancer Treat Rev 33(5):419–426PubMedCrossRef Pavlidis N, Vermorken JB, Stahel R et al (2007) Oncology for medical students: a European school of oncology contribution to undergraduate cancer education. Cancer Treat Rev 33(5):419–426PubMedCrossRef
3.
go back to reference Omar S, Alieldin NMH, Khatib OMN (2007) Cancer magnitude, challenges and control in the Eastern Mediterranean Region. East Mediterr Health J 13(6):1486–1496PubMed Omar S, Alieldin NMH, Khatib OMN (2007) Cancer magnitude, challenges and control in the Eastern Mediterranean Region. East Mediterr Health J 13(6):1486–1496PubMed
Metadata
Title
Teaching Oncology to Medical Students is a Must: The Egyptian NCI Step on the Road
Authors
Rabab Gaafar
Emad Shash
Alaa El-Haddad
Salah Abdel Hady
Publication date
01-09-2011
Publisher
Springer-Verlag
Published in
Journal of Cancer Education / Issue 3/2011
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-011-0214-2

Other articles of this Issue 3/2011

Journal of Cancer Education 3/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine